Literature DB >> 23903214

Novelty in the target landscape of the pharmaceutical industry.

Pankaj Agarwal, Philippe Sanseau, Lon R Cardon.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23903214     DOI： 10.1038/nrd4089

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  Competitiveness in follow-on drug R&D: a race or imitation?

Authors:  Joseph A DiMasi; Laura B Faden
Journal:  Nat Rev Drug Discov       Date:  2010-12-10       Impact factor: 84.694
  1 in total
  7 in total

Review 1.  Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications.

Authors:  Hsin-Pei Shih; Xiaodan Zhang; Alex M Aronov
Journal:  Nat Rev Drug Discov       Date:  2017-10-27       Impact factor: 84.694

2.  Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants.

Authors:  Kasper Harpsøe; Vignir Isberg; Benjamin G Tehan; Dahlia Weiss; Angela Arsova; Fiona H Marshall; Hans Bräuner-Osborne; David E Gloriam
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

Review 3.  Natural product drug discovery in the artificial intelligence era.

Authors:  F I Saldívar-González; V D Aldas-Bulos; J L Medina-Franco; F Plisson
Journal:  Chem Sci       Date:  2021-12-13       Impact factor: 9.825

Review 4.  A comprehensive map of molecular drug targets.

Authors:  Rita Santos; Oleg Ursu; Anna Gaulton; A Patrícia Bento; Ramesh S Donadi; Cristian G Bologa; Anneli Karlsson; Bissan Al-Lazikani; Anne Hersey; Tudor I Oprea; John P Overington
Journal:  Nat Rev Drug Discov       Date:  2016-12-02       Impact factor: 84.694

5.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

Review 6.  Changing R&D models in research-based pharmaceutical companies.

Authors:  Alexander Schuhmacher; Oliver Gassmann; Markus Hinder
Journal:  J Transl Med       Date:  2016-04-27       Impact factor: 5.531

7.  Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues.

Authors:  Vinod Kumar; Philippe Sanseau; Daniel F Simola; Mark R Hurle; Pankaj Agarwal
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.